Skip to main content

Table 1 Patient demographics and intraoperative data (n = 590)

From: Relationship between estimated and observed heparin sensitivity indices in cardiac and thoracic aortic surgery

 

Total (n = 590)

Heparin resistance (-) (n = 397)

Heparin resistance ( +) (n = 193)

P value

Age (yr)

68.6 (11.6)

68.6 (11.5)

68.6 (11.9)

0.98

Female

329 (55.8)

235 (59.2)

94 (48.7)

0.01

Body mass index (kg/m2)

23.3 (3.6)

23.6 (3.6)

22.8 (3.5)

0.007

Current smoking

37 (6.3)

25 (6.3)

12 (6.2)

 > 0.99

Hypertension

418 (70.8)

287 (72.3)

131 (67.9)

0.28

Symptomatic cerebral disease

11 (1.9)

7 (1.8)

4 (2.1)

0.75

Hemodialysis

42 (7.1)

24 (6.0)

18 (9.3)

0.17

Daily medication

 Beta blocker

197 (33.4)

139 (35.0)

58 (30.1)

0.26

 Digitalis

21 (3.6)

15 (3.8)

6 (3.1)

0.81

 Intravenous nitrate solution

155 (26.3)

105 (26.4)

50 (25.9)

0.92

Specific disease

 Infective endocarditis

34 (5.8)

23 (5.8)

11 (5.7)

 > 0.99

 Dissection of aorta (acute and chronic)

47 (8.0)

31 (7.8)

16 (8.3)

0.87

Laboratory data

 Aspartate aminotransferase (IU/L)

31 (104)

34 (126)

25 (16)

0.3

 Alanine aminotransferase (IU/L)

26 (111)

29 (134)

20 (21)

0.36

 Platelet (104/μL)

19.6 (6.7)

18.9 (6.3)

21.0 (7.3)

 < 0.001

 Fibrinogen (mg/dL)

355 (133)

345 (124)

377 (147)

0.007

 Serum albumin (d/dL)

3.9 (0.5)

3.9 (0.5)

3.9 (0.5)

0.47

 Fibrinogen albumin ratio index

9.4 (4.8)

9.1 (4.3)

10.2 (5.7)

0.01

 Antithrombin (%)

96 (17)

95 (16)

97 (17)

0.25

 Serum creatinine (mg/dL)

1.49 (1.9)

1.39 (1.6)

1.71 (2.4)

0.05

 Prothrombin time-international normalized ratio

1.11 (0.2)

1.12 (0.2)

1.09 (0.2)

0.21

 Activated partial thromboplastin time (s)

29.6 (4.6)

30.1 (4.7)

28.5 (4.1)

 < 0.001

Intraoperative data

 Surgical procedure*

  

0.005

  Valve

277 (46.9)

191 (48.1)

86 (44.6)

 

  Coronary artery

127 (21.5)

99 (24.9)

28 (14.5)

 

  Aorta

198 (33.6)

122 (30.7)

76 (39.4)

 

  Others

79 (13.4)

46 (11.6)

33 (17.1)

 

Baseline activated clotting time (s)

154 (16)

156 (16)

149 (17)

 < 0.001

Initial heparin dose (u/kg)

275 (29)

279 (29)

269 (28)

 < 0.001

Activated clotting time after initial heparin administration (s)

555 (150)

624 (134)

415 (57)

 < 0.001

Surgical duration (min)

415(148)

418 (147)

409 (150)

0.48

Blood loss volume (mL)

1732 (1892)

1768 (1871)

1659 (1937)

0.51

  1. Mean (standard deviation) or number (%)
  2. *Number of patients who underwent multiple surgical procedures (e.g., aortic valve replacement and coronary artery bypass grafting)